Nomegestrol acetate contraceptive implant use by women with sickle cell disease

Clinical Pharmacology and Therapeutics

Volumn 64, Issue 4, 1998, Pages 433-438

  Nascimento, Maria De Lourdes Pires ^a   Ladipo, Oladipo A ^a   Coutinho, Elsimar M ^a  

^a 273 Edf Itaporã ^*

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; FERRITIN; NOMEGESTROL ACETATE;

ADULT; ANEMIA; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRACEPTION; CONTROLLED STUDY; DRUG IMPLANT; DRUG SAFETY; FEMALE; FERRITIN BLOOD LEVEL; HEMATOLOGICAL PARAMETERS; HUMAN; INTRADERMAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SICKLE CELL ANEMIA; TREATMENT OUTCOME;

ADULT; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; FEMALE; HUMANS; MEGESTROL; NORPREGNADIENES; PROGESTERONE CONGENERS; PROSPECTIVE STUDIES;

EID: 13144269567     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90074-1     Document Type: Article

References (38)

1. World Health Organization. Prevention and management of severe anaemia in pregnancy. Report of a technical working group; Geneva; May 20-22, 1991. 1993: WHO/FHE/MSM/935. p. 7.
2. Davies SC, Brozovic M. The presentation, management and prophylaxis of sickle cell disease. Blood Rev 1989; 3:29-44.
3. Hunt JA, Ingram VM. A terminal peptide sequence of human haemoglobin. Nature 1959;184:640-1.
4. Ingram VM. Gene mutation in human hemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 1957;180:326-8.
5. Paulin L, Itano HA, Singer SJ, Wells IC. Sickle cell anemia, molecular disease. Science 1949;110:543-8.
6. Blau A, Constantoulakis P, Shaw CM, Stamatoyan-noupoulos G. Fetal hemoglobin induction with butyric acid: efficacy and toxicity. Blood 1993;81:529-37.
7. Carache S, Dover GJ, Smith KD, Talbot CC, Moyer M, Boyer S. Treatment of sickle cell with 5-azacytidine results in increased fetal hemoglobin production and is associated with non-random hypomethylation of DNA around the alpha-beta globulin gene complex. Proc Natl Acad Sci USA 1983;80:4842-6.
8. De Simone J, Heller P, Hall L, Zwiers D. 5-Azacytidine stimulates fetal haemoglobin synthesis in anemic baboons. Proc Natl Acad Sci USA 1982;79:4428-31.
9. Goldeberg MA, Brugnara C, Dover GJ, Schapira L, Carache S, Bunn HF. Treatment of sickle cell anemia with hydroxyurea and erythropoietin. N Engl J Med 1990;323:366-72.
10. Noguchi CT, Rodgersm GP, Sergeant G, Schechter AN. Levels of fetal haemoglobin necessary for treatment of sickle cell disease. N Engl J Med 1988;318:95-9.
11. Stamatoyannoupoulos G, Nienhuis A. Hemoglobin switching. In: Stamatoyannopoulos G, Nienhuis A, Leder P, Majerus P, editors. The molecular basis of blood diseases. Philadelphia: Saunders; 1987. p. 66-126.
12. Steinberg MH, Dreiling BL. Clinical hematologic and biosynthetic studies in sickle cell beta-thalassemia: a comparison with sickle cell anaemia. Am J Hematol 1976:1:35-44.
13. Isaacs WA, Hayhoe FGJ. Steroid hormones in sickle cell disease. Nature 1967;215:1139-42.
14. De Ceulaer K, Gruber C, Hayes R, Sergeant GR. Medroxyprogesterone acetate and homozygous sickle cell disease. Lancet 1982;2:229-31.
15. Coutinho EM. One year contraception with a single subdermal implant containing nomegestrol acetate (Uniplant). Contraception 1993;47:97-105.
16. Dacie JV, Lewis SM. Practical haematology, London: Churchill Livingstone; 1984. p. 110-1.
17. Marengo-Rowe AJ. Rapid electrophoresis and quantitation of human on cellulose acetate. J Clin Pathol 1965;18:790-2.
18. Betke K, Marti HR, Schlicht I. Estimation of small percentages of foetal hemoglobin. Nature 1969;184:1877-8.
19. International Committee for Standardization in Hematology. Recommendations for fetal hemoglobin reference preparations and fetal haemoglobin determination by the alkali denaturation method. Br J Haematol 1979;42:133-6.
20. Shephard HJ. Coloração da Hemoglobina F nos globulos vermelhos. In: Wallett LHB, Robinson JB, editors. Human haemoglobin: variants and their identification. London: Butterworth; 1975. p. 75-6.
21. Miale JB. Laboratory medicina hematology. 5th ed. St Louis: CV Mosby; 1977. p. 1003.
22. Cooper GR, Mc Daniel V. The determination of glucose by the ortho-toluidin method. Clin Chem 1970;6:159-70.
23. Adadevoh BK, Isaacs WA. The effect of megestrol acetate on sickling. Am J Med Sci 1973;265:367-70.
24. Isaacs WA, Effiong CE, Ayeni O. Steroid treatment in the prevention of painful episodes in sickle cell disease. Lancet 1972;1:570-1.
25. Oliveira PH. Hematologia clínica. 1st ed. Sao Paulo, Brazil: Livraria Atheneu; 1978. p. 92-3.
26. Agarwal KC, Parks RE Jr, Widness JA, Schwartz R. Nonenzymatic glycosylation of erythrocytic proteins in normal and diabetic subjects. Diabetes 1985;34:251-5.
27. McDonald MJ, Bleichman M, Bunn HF, Noble RW. Functional properties of the glycosylated minor components of human adult hemoglobin. J Biol Chem 1979;254:701-2.
28. Ravel R. Laboratorio clínico. 4th ed. Rio de Janeiro, Brazil: Guanabara Koogan; 1988. p. 275-6.
29. Erslev AJ, Gabuzda TG. Fisiologia dos Disturbios Hematológicos. In: William A, Sodeman T Jr, Sodeman TM, editors. Rio de Janeiro: Fisiologia Patológica-Interamericana Ltd; 1983.
30. Maeda N, Kon K, Imaizumi K, Sekiya M, Shiga T. Alteration of Theological properties of human erythrocytes by crosslinking of membrane proteins. Biochim Biophys Acta 1983;733:104-12.
31. Chuí DHK, Wong SC, Enkim MW, Patterson M, Ives RA. Proportion of fetal hemoglobin synthesis decreases during erythroid cell maturation. Proc Natl Acad Sci USA 1980;77:2757-61.
32. Singer JW, Samuels AI, Adamson JW. Steroids and hematopoiesis; I: the effect of steroids on in vitro erythroid colony structure activity relationships. J Cell Physiol 1976;88:127-33.
33. Singer JW, Adamson JW. Steroids and hematopoiesis; II: the effects of steroids on in vitro erythroid colony growth: evidence for different target cells for different classes of steroids. J Cell Physiol 1976;88:135-43.
34. Boyer SH, Belding TK, Margolet L, Noyes AN, Burke PJ, Bell WR. Variations in the frequency of fetal hemoglobin-bearing erythrocytes (F-cells) in well adults, pregnant women, and adult leukemics. Johns Hopkins Med J 1975;137:105-15.
35. Boyer SH, Margolet L, Boyer ML, Huisman TH, Schoreder WA, et al. Inheritance of F-cell frequency in heterocellular persistence of fetal hemoglobin: an example. Am J Hum Genet 1977;29:256-71.
36. Nascimento MLP, Gonçalves MS, Guedes MLC. Different clinical interpretation for fetal hemoglobin. Rev Bras Pat Clin 1985;21:78-83.
37. Carache S, Dover GJ, Moyer MA, Moore JW. Hydroxyurea-induced augmentation of fetal hemoglobin production in patients with sickle cell anaemia. Blood 1987;69:109-16.
38. Dover GJ, Humphries RK, Moore JG, Ley TJ, Young NS, Carache S, et al. Hydroxyurea induction of hemoglobin F production in sickle cell disease: relationship between cytotoxicity and F-cell production. Blood 1986;67:735-8.